Clinical trial
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
NCT03490461 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation
- Lead sponsor
- Yonsei University
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 22, 2017
- Completion date
- March 1, 2018
- Enrollment
- 350 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma